XML 54 R37.htm IDEA: XBRL DOCUMENT v3.20.4

Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2020

Segment Reporting [Abstract]

Schedule of Segment Revenue and Operating Income

The following tables present financial information for each reportable segment (in millions):

						Year Ended December 31,
						2020						2019						2018
Revenues:
Surgical Facility Services						$	1,793.4					$	1,748.2					$	1,682.4
Ancillary Services						63.6						79.4						79.6
Optical Services						3.1						3.8						9.5
Total						$	1,860.1					$	1,831.4					$	1,771.5
Adjusted EBITDA:
Surgical Facility Services						$	339.3					$	328.9					$	309.5
Ancillary Services						(3.4)						2.6						3.0
Optical Services						1.4						1.4						2.5
All other						(80.7)						(74.3)						(80.2)
Total						$	256.6					$	258.6					$	234.8
Reconciliation of Adjusted EBITDA:
(Loss) income before income taxes						$	(18.8)					$	54.6					$	(69.2)
Net income attributable to non-controlling interests						(117.4)						(119.9)						(110.1)
Depreciation and amortization						94.8						76.5						67.4
Interest expense, net						201.8						178.9						147.0
Equity-based compensation expense						13.2						10.2						9.3
Transaction, integration and acquisition costs (1)						38.2						36.1						34.0
Impairment charges						33.5						7.9						74.4
Loss (gain) on disposals and deconsolidations, net						5.7						(4.4)						31.8
Litigation settlement and other litigation costs (2)						6.4						4.6						46.0
Reserve adjustments (3)						—						—						2.7
Contingent acquisition compensation expense						—						—						1.5
Gain on escrow release (4)						(0.8)						—						—
Loss on debt extinguishment						—						11.7						—
Tax receivable agreement expense						—						2.4						—
Adjusted EBITDA						$	256.6					$	258.6					$	234.8

(1)For the year ended December 31, 2020, this amount includes transaction and integration costs of $23.2 million, of which $6.6 million were acquisition related costs, and includes start-up costs related to a de novo surgical hospital of $15.0 million. For the year ended December 31, 2019, this amount includes transaction and integration costs of $19.0 million, and includes other acquisition costs and start-up costs related to a de novo surgical hospital of $17.1 million. For the year ended December 31, 2018, this amount includes transaction and integration costs of $31.7 million, and includes other acquisition costs of $2.3 million.

(2)This amount includes litigation settlement costs of $1.2 million, $0.2 million and $46.0 million for the years ended December 31, 2020, 2019 and 2018, respectively. This amount further includes other litigation costs of $5.2 million and $4.4 million for the years ended December 31, 2020 and 2019, respectively, with no comparable costs in 2018.

(3)This amount represents adjustments to revenue in order to apply consistent policies to businesses acquired by Surgery Partners in prior periods.

(4)Included in other income in the consolidated statement of operations for the year ended December 31, 2020, with no comparable gain in 2019 and 2018.

Reconciliation of Assets from Segment to Consolidated

						December 31,
						2020						2019
Assets:
Surgical Facility Services						$	4,962.4					$	4,580.4
Ancillary Services						35.0						69.6
Optical Services						—						17.7
All other						415.8						351.2
Total assets						$	5,413.2					$	5,018.9

Schedule of Financial Information by Reportable Segment

						Year Ended December 31,
						2020						2019						2018
Cash purchases of property and equipment:
Surgical Facility Services						$	38.7					$	65.9					$	34.2
Ancillary Services						0.4						1.1						0.4
All other						3.8						6.6						5.2
Total cash purchases of property and equipment						$	42.9					$	73.6					$	39.8

X

- Definition

Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

+ Details

Name:	us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the reconciliation of profit (loss) from reportable segments to the consolidated income (loss) before income tax expense (benefit) and discontinued operations. Includes, but is not limited to, reconciliation after income tax if income tax is allocated to the reportable segment.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ReconciliationOfOperatingProfitLossFromSegmentsToConsolidatedTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration